Content
March 2004, Volume 13, Issue 3
- 251-264 The effect of prenatal care on birthweight: a full‐information maximum likelihood approach
by Jeffrey J. Rous & R. Todd Jewell & Robert W. Brown - 265-280 Empirical assessment of the economic behaviour of Dutch general hospitals
by J.L.T. Blank & A.H.Q.M. Merkies - 281-290 A multi‐method approach to measuring health‐state valuations
by Joshua A. Salomon & Christopher J.L. Murray - 291-296 A comparison of stated preference methods for estimating monetary values
by Mandy Ryan - 297-301 Overall versus socioeconomic health inequality: a measurement framework and two empirical illustrations
by Adam Wagstaff & Eddy van Doorslaer
February 2004, Volume 13, Issue 2
- 101-122 Using simulation‐based inference with panel data in health economics
by Paul Contoyannis & Andrew M. Jones & Roberto Leon‐Gonzalez - 123-137 The effects of price and policy on marijuana use: what can be learned from the Australian experience?
by J. Williams - 139-155 Does problem drinking affect employment? Evidence from England
by Ziggy MacDonald & Michael A. Shields - 157-169 Excess capacity and expense preference behaviour in National Health Systems: an application to the Spanish public hospitals
by Ana Rodríguez‐Álvarez & C. A. Knox Lovell - 171-181 Lack of multiplicative transitivity in person trade‐off responses
by Michaël Schwarzinger & Jean‐Louis Lanoë & Erik Nord & Isabelle Durand‐Zaleski - 183-190 Evidence of range bias in contingent valuation payment scales
by David K. Whynes & Jane L. Wolstenholme & Emma Frew - 191-198 Bayesian estimation of cost‐effectiveness: an importance‐sampling approach
by Daniel F. Heitjan & Huiling Li - 199-202 Managed care and shadow price
by Ching‐to A. Ma
January 2004, Volume 13, Issue 1
- 1-8 Insomnia, biological clock, and the bedtime decision: an economic perspective
by Gideon Yaniv - 9-19 Cost‐effectiveness analysis based on the number‐needed‐to‐treat: common sense or non‐sense?
by Ivar Sønbø Kristiansen & Dorte Gyrd‐Hansen - 21-35 Cost‐effectiveness analysis and health care resource allocation: decision rules under variable returns to scale
by Elamin H. Elbasha & Mark L. Messonnier - 37-48 Responses to standard gambles: are preferences ‘well constructed’?
by Rachel Baker & Angela Robinson - 49-58 The effects of higher cigarette prices on tar and nicotine consumption in a cohort of adult smokers
by M.C. Farrelly & C.T. Nimsch & A. Hyland & M. Cummings - 59-71 The value of risk‐free cigarettes – do smokers underestimate the risk?
by Henrik Hammar & Olof Johansson‐Stenman - 73-86 Increasing patient choice in primary care: the management of minor ailments
by Chris Bojke & Hugh Gravelle & Karen Hassell & Zoe Whittington - 87-94 Simulation of a Hirschman–Herfindahl index without complete market share information
by Eric Nauenberg & Mahdi Alkhamisi & Yuri Andrijuk - 100-100 Thirteenth European Workshop on Econometrics and Health Economics
by Andrew Jones
December 2003, Volume 12, Issue 12
- 985-1004 Modelling supply and demand influences on the use of health care: implications for deriving a needs‐based capitation formula
by Hugh Gravelle & Matthew Sutton & Stephen Morris & Frank Windmeijer & Alastair Leyland & Chris Dibben & Mike Muirhead - 1005-1020 Classical versus relational approaches to understanding controls on a contract with independent GPs in South Africa
by Natasha Palmer & Anne Mills - 1021-1034 Analysis of hospital length of stay and discharge destination using hazard functions with unmeasured heterogeneity
by Gabriel Picone & R. Mark Wilson & Shin‐Yi Chou - 1035-1047 An experiment on simplifying conjoint analysis designs for measuring preferences
by Tara Maddala & Kathryn A. Phillips & F. Reed Johnson - 1049-1060 Willingness to pay for a QALY
by Dorte Gyrd‐Hansen - 1061-1067 An empirical comparison of EQ‐5D and SF‐6D in liver transplant patients
by Louise Longworth & Stirling Bryan
November 2003, Volume 12, Issue 11
- 891-894 Willingness to pay methods in health care: a sceptical view
by Richard Cookson - 895-907 How much confidence should we place in efficiency estimates?
by Andrew Street - 909-919 If the price is right: vagueness and values clarification in contingent valuation
by Alan Shiell & Lisa Gold - 921-933 Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993–1998
by Adam Wagstaff & Eddy van Doorslaer - 935-947 Estimating mean hospital cost as a function of length of stay and patient characteristics
by Elena Polverejan & Joseph C. Gardiner & Cathy J. Bradley & Margaret Holmes‐Rovner & David Rovner - 949-958 Illustrating the impact of including future costs in economic evaluations: an application to end‐stage renal disease care
by Braden Manns & David Meltzer & Ken Taub & Cam Donaldson - 959-974 Estimating the marginal value of ‘better’ research output: ‘designed’ versus ‘routine’ data in randomised controlled trials
by David Cohen & Mirella F Longo & John Williams & Wai‐yee Cheung & Hayley Hutchings & I.T. Russell - 975-981 A view from the bridge: agreement between the SF‐6D utility algorithm and the Health Utilities Index
by Bernie J. O'Brien & Marian Spath & Gordon Blackhouse & J.L. Severens & Paul Dorian & John Brazier - 983-983 Book Review
by Sherry Glied
October 2003, Volume 12, Issue 10
- 797-801 Labour markets in the NHS: an agenda for research
by Bob Elliott - 803-819 Measuring income related inequality in health: standardisation and the partial concentration index
by Hugh Gravelle - 821-835 Cigarette demand: a meta‐analysis of elasticities
by Craig A. Gallet & John A. List - 837-848 Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation
by Jonathan Karnon - 849-862 Willingness‐to‐pay for community‐based insurance in Burkina Faso
by Hengjin Dong & Bocar Kouyate & John Cairns & Frederick Mugisha & Rainer Sauerborn - 863-871 Testing rank‐dependent utility theory for health outcomes
by Adam Oliver - 873-877 The value of life: individual preferences and social choice. A comment to Magnus Johannesson
by Erik Nord & Paul Menzel & Jeff Richardson - 879-884 Conservative versus aggressive follow up of mildly abnormal Pap smears: Testing for process utility
by Stephen Birch & Joy Melnikow & Miriam Kuppermann - 885-890 What difference does the choice of SES make in health inequality measurement?
by Adam Wagstaff & Naoko Watanabe
September 2003, Volume 12, Issue 9
- 703-704 Guest editors' introduction
by Andrew Jones & Owen O'Donnell - 705-719 Wage policy in the health care sector: a panel data analysis of nurses' labour supply
by Jan Erik Askildsen & Badi H. Baltagi & Tor Helge Holmås - 721-739 Economics of self‐medication: theory and evidence
by Fwu‐Ranq Chang & Pravin K. Trivedi - 741-754 Fixed fees and physician‐induced demand: A panel data study on French physicians
by Eric Delattre & Brigitte Dormont - 755-770 Why do the sick not utilise health care? The case of Zambia
by Catharina Hjortsberg - 771-790 A structural econometric model of family valuation and choice of employer‐sponsored health insurance in the United States
by David J. Vanness - 791-796 Willingness to pay and size of health benefit: an integrated model to test for ‘sensitivity to scale’
by Raymond Y.T. Yeung & Richard D. Smith & Sarah M. McGhee
August 2003, Volume 12, Issue 8
- 609-628 Construction of the contingent valuation market in health care:a critical assessment
by Richard D. Smith - 629-636 The missing link: on the line between C and E
by Werner B.F. Brouwer & Frans F.H. Rutten - 637-654 The value of the change in health in Sweden 1980/81 to 1996/97
by Kristina Burström & Magnus Johannesson & Finn Diderichsen - 655-668 The TTO method and procedural invariance
by Anne Spencer - 669-684 Hospital efficiency targets
by Rowena Jacobs & Diane Dawson - 685-696 Public spending on health care and the poor
by Sanjeev Gupta & Marijn Verhoeven & Erwin R. Tiongson - 697-702 Methodological issues raised by preference‐based approaches to measuring the health status of children
by Stavros Petrou
July 2003, Volume 12, Issue 7
- 517-527 Design and analysis of unit cost estimation studies: How many hospital diagnoses? How many countries?
by Henry A. Glick & Sean M. Orzol & Joseph F. Tooley & Daniel Polsky & Josephine O. Mauskopf - 529-544 Logical inconsistencies in survey respondents' health state valuations ‐ a methodological challenge for estimating social tariffs
by Nancy J. Devlin & Paul Hansen & Paul Kind & Alan Williams - 545-551 An inquiry into the different perspectives that can be used when eliciting preferences in health
by Paul Dolan & Jan Abel Olsen & Paul Menzel & Jeff Richardson - 553-564 Health‐seeking behaviour and rural/urban variation in Kazakhstan
by Robin Thompson & Nigel Miller & Sophie Witter - 565-586 Price elasticity and pharmaceutical selection: the influence of managed care
by Marisa Elena Domino & David S. Salkever - 587-599 Demand for private health insurance: how important is the quality gap?
by Joan Costa & Jaume Garcia - 601-608 Allocating health care resources when people are risk averse with respect to life time
by Michael Hoel
June 2003, Volume 12, Issue 6
- 431-451 Estimation of the determinants of household health care expenditures in Nepal with controls for endogenous illness and provider choice
by Jeffrey J. Rous & David R. Hotchkiss - 453-464 A preliminary investigation of the effects of restrictions on Medicaid funding for abortions on female STD rates
by Bisakha Sen - 465-478 The labour market for nursing: a review of the labour supply literature
by Emanuela Antonazzo & Anthony Scott & Diane Skatun & Robert. F. Elliott - 479-491 Conjoint analysis. The cost variable: an Achilles' heel?
by Ulla Slothuus Skjoldborg & Dorte Gyrd‐Hansen - 493-504 The efficiency of health production: re‐estimating the WHO panel data using parametric and non‐parametric approaches to provide additional information
by Bruce Hollingsworth & John Wildman - 505-510 The person trade‐off method and the transitivity principle: an example from preferences over age weighting
by Paul Dolan & Aki Tsuchiya - 511-516 A note on the decomposition of the health concentration index
by Philip M. Clarke & Ulf‐G Gerdtham & Luke B. Connelly
May 2003, Volume 12, Issue 5
- 339-354 Risk selection and matching in performance‐based contracting
by Mingshan Lu & Ching‐to Albert Ma & Lasheng Yuan - 355-366 A critique of the World Health Organisation's evaluation of health system performance
by Jeff Richardson & John Wildman & Iain K. Robertson - 367-376 Determinants of health care utilization by German sickness fund members ‐ with application to risk adjustment
by Friedrich Breyer & Martin Heineck & Normann Lorenz - 377-392 Missing.... presumed at random: cost‐analysis of incomplete data
by Andrew Briggs & Taane Clark & Jane Wolstenholme & Philip Clarke - 393-402 Threats to the estimation of benefit: are preference elicitation methods accurate?
by Andrew J Lloyd - 403-414 A bibliometric analysis of health economics articles in the economics literature: 1991‐2000
by Rose M. Rubin & Cyril F. Chang - 415-419 Measles vaccination improves the equity of health outcomes: evidence from Bangladesh
by David Bishaia & Michael Koenig & Mehrab Ali Khan - 421-427 Stratified cost‐effectiveness analysis: a framework for establishing efficient limited use criteria
by Douglas Coyle & Martin J. Buxton & Bernie J. O'Brien - 429-429 Health Economics: An International Perspective, by Barbara Mcpake, Lilani Kumaranayake and Charles Normand. Routledge, London and New York, 2002. No. of pages: 260. ISBN 0‐415‐27736‐1
by Dave Whynes - 430-430 Advances in Health Economics, by Anthony Scott, Alan Maynard and Robert Elliott (Eds). John Wiley and Sons Ltd, Chichester, 2002. No. of pages: xxi+249. ISBN 0‐470‐84883‐9
by Alan Williams
April 2003, Volume 12, Issue 4
- 255-267 Does it matter who you are or what you gain? an experimental study of preferences for resource allocation
by David L.B. Schwappach - 269-280 Health status and heterogeneity of cost‐sharing responsiveness: how do sick people respond to cost‐sharing?
by Dahlia K. Remler & Adam J. Atherly - 281-294 Design techniques for stated preference methods in health economics
by Fredrik Carlsson & Peter Martinsson - 295-307 Revisiting the axiom of completeness in health care
by Mandy Ryan & Fernando San Miguel - 309-321 The changing public/private mix in dentistry in the UK–a supply‐side perspective
by Mauricea Lynch & Michael Calnan - 323-334 Measuring the value of time for methadone maintenance clients: willingness to pay, willingness to accept, and the wage rate
by Natalia N. Borisova & Allen C. Goodman - 335-335 Econometric analysis of health data, by Andrew Jones and Owen O'Donnell (eds). John Wiley & Sons Ltd, Chichester, 2002. No. of pages: 233. ISBN 0 470 84145 1
by John Mullahy
March 2003, Volume 12, Issue 3
- 171-186 An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population
by Jack Hadley & Daniel Polsky & Jeanne S. Mandelblatt & Jean M. Mitchell & Jane C. Weeks & Qin Wang & Yi‐Ting Hwang & OPTIONS Research Team - 187-198 Preferences and person trade‐offs: forcing consistency or inconsistency in health‐related quality of life measures?
by Edward C. Mansley & Elamin H. Elbasha - 199-215 The interaction between cost‐management and learning for major surgical procedures – lessons from asymmetric information
by Christian M. Ernst - 217-230 The effect of cigarette prices on youth smoking
by Hana Ross & Frank J. Chaloupka - 231-246 Medical care use and selection in a social health insurance with an equalization fund: evidence from Colombia
by Antonio J. Trujillo - 247-250 A note on cost‐value analysis
by Lars Peter Østerdal - 251-253 Comments to ‘a note on cost‐value analysis’
by Erik Nord & José Luis Pinto & Jeff Richardson & Paul Menzel & Peter Ubel
February 2003, Volume 12, Issue 2
- 87-100 A cost‐minimisation study of alternative discharge policies after hip fracture repair
by Johan J. Polder & Romke van Balen & Ewout W. Steyerberg & Herman J.M. Cools & J. Dik F. Habbema - 101-112 Medical student indebtedness and the propensity to enter academic medicine
by Marc Fox - 113-124 The determinants of health care expenditure: testing pooling restrictions in small samples
by Helmut Herwartz & Bernd Theilen - 125-138 Deadweight loss of bacterial resistance due to overtreatment
by Elamin H. Elbasha - 139-148 How measures of perception from survey data lead to inconsistent regression results: evidence from adolescent and peer substance use
by Edward C. Norton & Richard C. Lindrooth & Susan T. Ennett - 149-158 Managed care and technical efficiency
by H. Shelton Brown - 159-162 Determining the optimal combinations of mutually exclusive interventions: a response to Hutubessy and colleagues
by Douglas Coyle - 163-164 Formal response to ‘Determining the optimal combinations of mutually exclusive interventions: a response to Hutubessy and colleagues’
by Rob M.P.M. Baltussen & Raymond C.W. Hutubessy & Jan J. Barendregt & David B. Evans & Christopher J.L. Murray - 165-169 Double discounting of QALYs
by Linda D. MacKeigan & Amiram Gafni & Bernie J. O'Brien
January 2003, Volume 12, Issue 1
- 1-2 Announcement and Editorial
by John Hutton & Andrew Jones & Alan Maynard - 3-16 Estimating the monetary value of health care: lessons from environmental economics
by Nick Hanley & Mandy Ryan & Robert Wright - 17-31 A utility‐theoretic model for QALYs and willingness to pay
by Thomas Klose - 33-49 Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?
by Anthony O'Hagan & John W. Stevens - 51-64 Eliciting several willingness to pay in a single contingent valuation survey: application to health care
by Stéphane Luchini & Christel Protière & Jean‐Paul Moatti - 65-66 Comment on Amartya Sen's ‘why health equity’
by Alan Williams - 67-73 How important are economic factors in choice of medical specialty?
by James Thornton & Fred Esposto - 75-76 Book Review
by John Appleby
December 2002, Volume 11, Issue 8
- 659-666 Why health equity?
by Amartya Sen - 667-677 Reducing avoidable inequalities in health: a new criterion for setting health care capitation payments
by Katharina Hauck & Rebecca Shaw & Peter C. Smith - 679-693 QALY‐maximisation and public preferences: results from a general population survey
by Stirling Bryan & Tracy Roberts & Chris Heginbotham & Alison McCallum - 695-708 A theoretical model of adolescent suicide and some evidence from US data
by Vijay K. Mathur & Donald G. Freeman - 709-722 The subjective costs of health losses due to chronic diseases. An alternative model for monetary appraisal
by Ada Ferrer‐i‐Carbonell & Bernard M.S. van Praag - 723-734 The importance of being first: evidence from Canadian generic pharmaceuticals
by Aidan Hollis - 735-739 Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods
by Nicholas Graves & Damian Walker & Rosalind Raine & Andrew Hutchings & Jennifer A. Roberts
October 2002, Volume 11, Issue 7
- 571-584 Do competition and managed care improve quality?
by Nazmi Sari - 585-598 Revealed preference valuation compared to contingent valuation: radon‐induced lung cancer prevention
by Christine A. Kennedy - 599-622 A comparison of consensus and nonconsensus approaches to modeling contraceptive choice behavior
by Li‐Wei Chao - 623-635 Willingness to pay for health risk reduction in the context of altruism
by Jorge E. Araña & Carmelo J. León - 637-647 Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?
by Joanna Coast & Richard Smith & Anne‐Marie Karcher & Paula Wilton & Michael Millar - 649-651 Recognising diversity in public preferences: the use of preference sub‐groups in cost‐effectiveness analysis. A response to Sculpher and Gafni
by Angela Robinson & David Parkin - 653-654 Recognising diversity in public preferences: the use of preference sub‐groups in cost‐effectiveness analysis. Authors' reply
by Mark Sculpher & Amiram Gafni - 655-658 Decision making heuristics and the elicitation of preferences: being fast and frugal about the future
by John Cairns & Marjon van der Pol & Andrew Lloyd
September 2002, Volume 11, Issue 6
- 469-470 Guest Editors' Introduction
by Andrew Jones & Owen O'Donnell - 471-483 Disentangling the effects of morbidity and life expectancy on labor market outcomes
by M. Christopher Auld - 485-491 Rational addiction to alcohol: panel data analysis of liquor consumption
by Badi H. Baltagi & James M. Griffin - 493-503 Keeping nurses at work: a duration analysis
by Tor Helge Holmås - 505-520 An econometric analysis of the mental‐health effects of major events in the life of older individuals
by Maarten Lindeboom & France Portrait & Gerard J. van den Berg - 521-535 How important are tobacco prices in the propensity to start and quit smoking? An analysis of smoking histories from the Spanish National Health Survey
by Angel López Nicolás - 537-549 Vertical and horizontal aspects of socio‐economic inequity in general practitioner contacts in Scotland
by Matthew Sutton - 551-566 Bayesian estimation, simulation and uncertainty analysis: the cost‐effectiveness of ganciclovir prophylaxis in liver transplantation
by David J. Vanness & W. Ray Kim - 567-568 The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2001. No. of pages: 320. ISBN 0‐335‐20900‐9
by Nancy J. Devlin
July 2002, Volume 11, Issue 5
- 377-387 Does prospective payment reduce inpatient length of stay?
by Edward C. Norton & Courtney Harold Van Houtven & Richard C. Lindrooth & Sharon‐Lise T. Normand & Barbara Dickey - 389-402 The benefits of switching smoking cessation drugs to over‐the‐counter status
by Theodore E. Keeler & Teh‐wei Hu & Alison Keith & Richard Manning & Martin D. Marciniak & Michael Ong & Hai‐Yen Sung - 403-413 The impact of diabetes on adult employment and earnings of Mexican Americans: Findings from a community based study
by Elena Bastida & José A. Pagán - 415-430 Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis
by Jeffrey S. Hoch & Andrew H. Briggs & Andrew R. Willan - 431-446 Social risk management options for medical care in Indonesia
by Menno Pradhan & Nicholas Prescott - 447-456 A new explanation for the difference between time trade‐off utilities and standard gamble utilities
by Han Bleichrodt - 457-465 Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination
by Jane Hall & Patricia Kenny & Madeleine King & Jordan Louviere & Rosalie Viney & Angela Yeoh - 467-468 Health economics resources ‐ an update
by Bruce Hollingsworth
June 2002, Volume 11, Issue 4
- 285-299 Prenatal screening for cystic fibrosis: an economic analysis
by Randi Nielsen & Dorte Gyrd‐Hansen - 301-321 Latent class versus two‐part models in the demand for physician services across the European Union
by Sergi Jiménez‐Martín & José M. Labeaga & Maite Martínez‐Granado - 323-340 Do Medicare HMOs still reduce health services use after controlling for selection bias?
by Michelle M. Mello & Sally C. Stearns & Edward C. Norton - 341-353 Estimating an EQ‐5D population value set: the case of Japan
by Aki Tsuchiya & Shunya Ikeda & Naoki Ikegami & Shuzo Nishimura & Ikuro Sakai & Takashi Fukuda & Chisato Hamashima & Akinori Hisashige & Makoto Tamura - 355-370 Discounting and clinical decision making: Physicians, patients, the general public, and the management of asymptomatic abdominal aortic aneurysms
by S. Höjgård & U. Enemark & C. H. Lyttkens & A. Lindgren & T. Troëng & H. Weibull - 371-376 Unit root properties of OECD health care expenditure and GDP data
by Garry MacDonald & Sandra Hopkins
April 2002, Volume 11, Issue 3
- 185-191 On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales
by Stephen Birch & Amiram Gafni - 193-206 Neonatal health care costs related to smoking during pregnancy
by E. Kathleen Adams & Vincent P. Miller & Carla Ernst & Brenda K. Nishimura & Cathy Melvin & Robert Merritt - 207-220 On the empirical association between poor health and low socioeconomic status at old age
by Christian Salas - 221-231 A general model of the impact of absenteeism on employers and employees
by Mark V. Pauly & Sean Nicholson & Judy Xu & Dan Polsky & Patricia M. Danzon & James F. Murray & Marc L. Berger - 233-248 Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost‐effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer
by N. Neymark & I. Adriaenssen & T. Gorlia & S. Caleo & M. Bolla - 249-264 Statistical determination of cost‐effectiveness frontier based on net health benefits
by Eugene M. Laska & Morris Meisner & Carole Siegel & Joseph Wanderling - 265-273 Morality and the limits of societal values in health care allocation
by Rebecca L. Walker & Andrew W. Siegel - 275-280 The familywise error rate of a simultaneous confidence band for the incremental net health benefit
by Morris Meisner & Eugene M. Laska & Carole Siegel & Joseph Wanderling - 281-284 The European Union and Health Policy, by Ed Randall. Palgrave, Hampshire and New York, 2001. No. of pages: xiii+278. ISBN 0‐333‐75426‐3.. The Implications of Recent Jurisprudence on the Co‐ordination of Health Care Protection Systems, by Willy Palm, Jason Nickless, Henri Lewalle and Alain Coheur. Association Internationale de la Mutualite, Brussess, 2000. No. of pages: 170. [http://europa.eu.int/comm/employment_social/soc‐prot/disable/report.pdf]. Health Care Without Frontiers? The Development of a European Market in Health Services by Lyndsay Mountford. Office of Health Econ‐omics, London, 2000. No. of pages: 83. ISBN 1‐899040‐71‐4
by Elias Mossialos
March 2002, Volume 11, Issue 2
- 93-101 The World Health Report 2000: dialogue of the deaf?
by Kjeld Møller Pedersen - 103-115 Reflections on and alternatives to WHO's fairness of financial contribution index
by Adam Wagstaff - 117-127 Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care
by Philip M. Clarke - 129-139 Measuring willingness‐to‐pay for risk reduction: an application of conjoint analysis
by Harry Telser & Peter Zweifel - 141-154 Socio‐economic health inequalities in Brazil: gender and age effects
by M. Dolores Montoya Diaz - 155-163 Obtaining disability weights in rural Burkina Faso using a culturally adapted visual analogue scale
by R.M.P.M. Baltussen & M. Sanon & J. Sommerfeld & R. Würthwein - 165-174 How profitable is risk selection? A comparison of four risk adjustment models
by Yujing Shen & Randall P. Ellis - 175-180 Is there a kink in consumers' threshold value for cost‐effectiveness in health care?
by Bernie J. O'Brien & Kirsten Gertsen & Andrew R. Willan & A. Faulkner - 181-181 Health Economics for Developing Countries. A Practical Guide, by S. Witter, T. Ensor, M. Jowett and R. Thompson. MacMillan Education, London, 2000. No. of pages: 296. ISBN 0‐333‐75205‐8
by Stephen Jan - 182-182 User Fees for Health Services: Guidelines for Protecting the Poor, by William Newbrander, David Collins and Lucy Gilson. Management Sciences for Health, Boston, 2001. No. of pages: 74. ISBN 0‐913‐723‐80‐0.. Ensuring Equal Access to Health Services: User fee Systems and the Poor, by William Newbrander, David Collins and Lucy Gilson. Management Sciences for Health, Boston, 2001. No. of pages: 200. ISBN 0‐913‐723‐79‐7
by Sophie Witter
January 2002, Volume 11, Issue 1
- 1-8 Decision validity should determine whether a generic or condition‐specific HRQOL measure is used in health care decisions
by Jack Dowie - 9-12 Commentary on Jack Dowie, “Decision validity should determine whether a generic or condition‐specific HRQOL measure is used in health care decisions”
by Gordon Guyatt - 13-16 Commentary on Jack Dowie, “Decision validity should determine whether a generic or condition‐specific HRQOL measure is used in health care decisions”
by David Feeny - 17-19 Measures of health‐related quality of life in an imperfect world: a comment on Dowie
by John Brazier & Ray Fitzpatrick - 21-22 ‘Decision validity…’: A rejoinder
by Jack Dowie - 23-31 Opportunity costs and uncertainty in the economic evaluation of health care interventions
by P. Sendi & A. Gafni & S. Birch - 33-42 Estimation of the transition matrix of a discrete‐time Markov chain
by Bruce A. Craig & Peter P. Sendi - 43-53 Measuring the social importance of concentration or dispersion of individual health benefits
by Eva Rodríguez‐Míguez & José‐Luis Pinto‐Prades - 55-70 The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes
by Cam Donaldson & Stephen Birch & Amiram Gafni - 71-85 The practicality and validity of directly elicited and SF‐36 derived health state preferences in patients with low back pain
by William Hollingworth & Richard A. Deyo & Sean D. Sullivan & Scott S. Emerson & Darryl T. Gray & Jeffrey G. Jarvik - 87-88 Health economics: an evolving paradigm but sailing in the wrong direction? A view from the front line
by David Kernick
December 2001, Volume 10, Issue 8
- 683-698 How reliable are hospital efficiency estimates? Exploiting the dual to homothetic production
by Sherman T. Folland & Richard A. Hofler - 699-714 Family health effects: complements or substitutes
by Michael Lee Ganz - 715-729 Twenty years of health care economic analysis in Spain: are we doing well?
by Anna García‐Altés - 731-749 Changing the first line drug for malaria treatment—cost‐effectiveness analysis with highly uncertain inter‐temporal trade‐offs
by Catherine A. Goodman & Paul G. Coleman & Anne J. Mills - 751-774 Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000)
by Philippe Beutels - 775-778 Methodological limitations of economic evaluations of antenatal screening
by Stavros Petrou - 779-787 Representing uncertainty: the role of cost‐effectiveness acceptability curves
by Elisabeth Fenwick & Karl Claxton & Mark Sculpher
October 2001, Volume 10, Issue 7
- 573-577 Should we aggregate relative or absolute changes in QALYs?
by Magnus Johannesson - 579-581 The desirability of a condition versus the well being and worth of a person
by Erik Nord - 583-585 The ‘fair innings argument’ deserves a fairer hearing! comments by Alan Williams on Nord and Johannesson
by Alan Williams - 587-599 Discounting for health effects in cost–benefit and cost‐effectiveness analysis
by Hugh Gravelle & Dave Smith - 601-615 The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature
by Dyfrig A. Hughes & Adrian Bagust & Alan Haycox & Tom Walley - 617-634 Analysing public preferences for cancer screening programmes
by Dorte Gyrd‐Hansen & Jes Søgaard - 635-649 Paradigms and research programmes: is it time to move from health care economics to health economics?
by Rhiannon Tudor Edwards - 651-668 The physician–patient relationship as a game of strategic information transmission
by Kris De Jaegher & Marc Jegers